These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 7859891

  • 1. Medical hypothesis: cardiovascular complications of diabetes mellitus-from glucose to insulin and back.
    Giugliano D, Acampora R, D'Onofrio F.
    Diabete Metab; 1994; 20(5):445-53. PubMed ID: 7859891
    [Abstract] [Full Text] [Related]

  • 2. [Epidemiology of cardio-vascular complications of diabetes].
    Grimaldi A, Heurtier A.
    Diabetes Metab; 1999 Jun; 25 Suppl 3():12-20. PubMed ID: 10421988
    [Abstract] [Full Text] [Related]

  • 3. Hyperglycaemia and its relation to cardiovascular morbidity and mortality: has it been resolved?
    Yosefy C.
    Acta Diabetol; 2003 Dec; 40 Suppl 2():S380-8. PubMed ID: 14704873
    [Abstract] [Full Text] [Related]

  • 4. Endothelial dysfunction in diabetes mellitus.
    Cosentino F, Lüscher TF.
    J Cardiovasc Pharmacol; 1998 Dec; 32 Suppl 3():S54-61. PubMed ID: 9883749
    [Abstract] [Full Text] [Related]

  • 5. Endothelial dysfunction and type 2 diabetes. Part 2: altered endothelial function and the effects of treatments in type 2 diabetes mellitus.
    Guerci B, Böhme P, Kearney-Schwartz A, Zannad F, Drouin P.
    Diabetes Metab; 2001 Sep; 27(4 Pt 1):436-47. PubMed ID: 11547217
    [Abstract] [Full Text] [Related]

  • 6. Insulin resistance and endothelial dysfunction: the road map to cardiovascular diseases.
    Cersosimo E, DeFronzo RA.
    Diabetes Metab Res Rev; 2006 Sep; 22(6):423-36. PubMed ID: 16506274
    [Abstract] [Full Text] [Related]

  • 7. Lifestyle modification and endothelial function in obese subjects.
    Hamdy O.
    Expert Rev Cardiovasc Ther; 2005 Mar; 3(2):231-41. PubMed ID: 15853597
    [Abstract] [Full Text] [Related]

  • 8. Parameters of antioxidative defense in type 2 diabetic patients with cardiovascular complications.
    Colak E, Majkić-Singh N, Stanković S, Srecković-Dimitrijević V, Djordjević PB, Lalić K, Lalić N.
    Ann Med; 2005 Mar; 37(8):613-20. PubMed ID: 16338763
    [Abstract] [Full Text] [Related]

  • 9. Von Willebrand factor in diabetic angiopathy.
    Kessler L, Wiesel ML, Attali P, Mossard JM, Cazenave JP, Pinget M.
    Diabetes Metab; 1998 Sep; 24(4):327-36. PubMed ID: 9805643
    [Abstract] [Full Text] [Related]

  • 10. [What do large clinical trials learn us about cardiovascular and renal prevention in patients with type 2 diabetes mellitus and hypertension?].
    Dussol B, Berland Y.
    Nephrol Ther; 2006 May; 2(2):51-74. PubMed ID: 16895717
    [Abstract] [Full Text] [Related]

  • 11. Diabetes mellitus, hypertension and ageing: the ionic hypothesis of ageing and cardiovascular-metabolic diseases.
    Barbagallo M, Resnick LM, Dominguez LJ, Licata G.
    Diabetes Metab; 1997 Sep; 23(4):281-94. PubMed ID: 9342541
    [Abstract] [Full Text] [Related]

  • 12. Type 2 diabetes mellitus. Aspects of complications and treatment.
    Wolffenbuttel BH.
    Neth J Med; 1993 Oct; 43(3-4):187-99. PubMed ID: 8302399
    [Abstract] [Full Text] [Related]

  • 13. [Cardiovascular risk factors and prevention in women: similarities and differences].
    Sclavo M.
    Ital Heart J Suppl; 2001 Feb; 2(2):125-41. PubMed ID: 11255880
    [Abstract] [Full Text] [Related]

  • 14. Glycaemic control is essential for effective cardiovascular risk reduction across the type 2 diabetes continuum.
    Karasik A.
    Ann Med; 2005 Feb; 37(4):250-8. PubMed ID: 16019723
    [Abstract] [Full Text] [Related]

  • 15. Diabetes and cardiovascular disease: explaining the relationship.
    Punthakee Z, Werstuck GH, Gerstein HC.
    Rev Cardiovasc Med; 2007 Feb; 8(3):145-53. PubMed ID: 17938614
    [Abstract] [Full Text] [Related]

  • 16. Role of postprandial hyperglycemia in cardiovascular disease.
    Fava S.
    Expert Rev Cardiovasc Ther; 2008 Jul; 6(6):859-72. PubMed ID: 18570623
    [Abstract] [Full Text] [Related]

  • 17. Effects of metabolic control and vascular complications on indices of oxidative stress in type 2 diabetic patients.
    Komosińska-Vassev K, Olczyk K, Olczyk P, Winsz-Szczotka K.
    Diabetes Res Clin Pract; 2005 Jun; 68(3):207-16. PubMed ID: 15936462
    [Abstract] [Full Text] [Related]

  • 18. Role of IGF-1 in glucose regulation and cardiovascular disease.
    Abbas A, Grant PJ, Kearney MT.
    Expert Rev Cardiovasc Ther; 2008 Sep; 6(8):1135-49. PubMed ID: 18793116
    [Abstract] [Full Text] [Related]

  • 19. Endothelial dysfunction in type 2 diabetes: effect of antioxidants.
    Sena CM, Nunes E, Louro T, Proença T, Seiça RM.
    Rev Port Cardiol; 2007 Jun; 26(6):609-19. PubMed ID: 17849945
    [Abstract] [Full Text] [Related]

  • 20. Primary prevention of cardiovascular disease in people with dysglycemia.
    Bianchi C, Miccoli R, Penno G, Del Prato S.
    Diabetes Care; 2008 Feb; 31 Suppl 2():S208-14. PubMed ID: 18227487
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.